NasdaqGS:PODDMedical Equipment
Insulet (PODD) Stock May Be Above Fair Value On Recall Lawsuit Risk
Insulet stock has fallen sharply over the past year, yet on current market multiples it still screens as expensive. This leaves investors weighing a weak share price record against valuation checks that do not flag a clear bargain.
Insulet has declined 44.7% over the last 12 months, which means the stock has given back a large amount of value despite more recent short term gains.
Product quality issues and related recalls around the Omnipod franchise can weigh on sentiment, while ongoing...